# Acurx Pharmaceuticals, Inc.: Form S-1, filed Feb 2, 2026

- Company: [Acurx Pharmaceuticals, Inc.](/companies/acxp.md) (CIK 1736243)
- Form: S-1
- Filed: 2026-02-02
- Accepted by EDGAR: Feb 2, 2026, 16:48 ET
- Period: not reported
- Accession: 0001104659-26-009266
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1736243/000110465926009266/tm264593-1_s1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736243/000110465926009266/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736243/000110465926009266/tm264593-1_s1.htm

Filed Feb 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-009266. Last ingested by Listed: Oct 29, 2026, 17:22 ET. No prices; not investment advice.